Author's posts
Billions Wiped From Covid Pharma Heavyweights—Including Moderna, Regeneron, Merck—As Pfizer’s Antiviral Pill Triggers Selloff
Pfizer jumped 8% Friday morning, while Moderna dropped 17.8%, Regeneron 6.2% and Merck 9%.
Novavax Covid-19 Vaccine Gets First Emergency Authorization In Indonesia—Here’s What You Need To Know
The shot marks the first time an older, protein-based shot has been approved to fight Covid-19 and the first vaccine Novavax has been able to bring to market in its 34-year history.
England On Track To Be First In World To Prescribe E-Cigarettes As Government Moves To Stamp Out Smoking
While not risk-free, e-cigarettes are less dangerous than cigarettes and can help people give up smoking, U.K. officials said.
Merck Sees Up To $1 Billion In Covid Antiviral Pill Sales—It Just Needs Regulatory Approval
Merck anticipates up to $7 billion in revenue from the drug through 2022, which it says can halve the risk of hospitalization and death in high-risk patients.
U.S. Purchases Additional 50 Million Pediatric Doses Of Covid-19 Vaccine, Pfizer Says
The additional doses finalize the 600 million dose deal the U.S. government made with Pfizer and BioNTech at the start of the pandemic.
1 In 5 Adults Still Reject Covid Vaccines, Poll Finds — Here Are The Biggest Groups Still Holding Out
Republicans, Americans living in rural areas and white evangelical Christians are among the groups most likely to reject the Covid-19 vaccine, according to the Kaiser Family Foundation.
Merck Inks Deal To Share Antiviral Covid Pill With Poorer Countries
The agreement, one of the first to share a critical Covid-19 technology, would allow the drug to be made and sold cheaply in 105 low- and middle-income countries.
Mammoth Biosciences Inks $691 Million Deal To Develop Crispr Gene-Editing Therapies
The deal will see Mammoth partner with Vertex Pharmaceuticals to develop gene-editing therapies to be delivered directly into the body.
Moderna Says Its Covid Shot Generates ‘Strong’ Immune Response In Kids Aged 6-11
The Massachusetts biotech said it plans to submit data to U.S. and European drug regulators in the “near term.”
Covid, Mental Health And High Costs—Here’s What Americans Say Are Their Biggest Health Problems
Two-thirds of Americans think many people in their country can’t afford good healthcare and just a quarter believe everybody gets the same standards of care, compared to global averages of 58% and 39%.
